{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:50:53Z","timestamp":1793296253938,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Primary ciliary dyskinesia (PCD) is a rare disease. There are no available data on disease-specific pediatric patient\u2013reported outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Our objective was to create developmentally appropriate, health-related quality-of-life questionnaires (QOL-PCD) for children (6\u201312 yr) and adolescents (13\u201317 yr) with PCD and a parent proxy measure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The QOL-PCD was developed using a cross-cultural protocol-driven approach satisfying both North American and European drug regulatory agency guidelines. A conceptual framework was generated by literature review, focus groups (expert clinicians and patients\/parents), and open-ended interviews with children, adolescents, and parents of patients with PCD. We recruited participants from international research consortiums, PCD clinics, and patient advocacy groups, aiming for representation of a wide spectrum of disease severity, sociodemographic status, and ethnicity. Qualitative interviews were conducted by trained and experienced research assistants and psychologists. Transcripts were content-analyzed with Atlas.ti\/NVivo to assess saturation of content. A self-completed item relevance survey was administered to E.U. participants. Qualitative and quantitative data were used to construct draft instruments. Questionnaires were further refined after cognitive interviews.<\/jats:p>\n                    <jats:p>Measurements and Main Results: Focus groups (n\u2009=\u200962 experts; n\u2009=\u200920 patients\/parents) and open-ended interviews with patients\/parents (n\u2009=\u200969; 34 males; age at diagnosis, 0\u201315 yr; FEV1, 58\u2013118% predicted) revealed a wide spectrum of issues unique to this population. Content analysis of transcripts identified the following domains, depending on age: Respiratory Symptoms, Physical Functioning, Emotional Functioning, Treatment Burden, Ears and Hearing, Sinus Symptoms, Social Functioning, Role Functioning, Vitality, Health Perceptions, School Functioning, and Eating and Weight. Various items were retained in questionnaires, based on age and role of respondent: 37, 43, and 41 items for children, adolescents, and parent proxy, respectively. The item relevance survey (n\u2009=\u200957) yielded results similar to those of open-ended interviews. Cognitive testing (n\u2009=\u200947; 20 males; age at diagnosis, 0\u201311 yr; FEV1, 49\u2013124% predicted) confirmed that items and response choices were clear and understood by respondents, and that all relevant items were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The QOL-PCD measures, developed using rigorous, protocol-driven methods and international collaborations, have demonstrated content validity and cross-cultural equivalence for implementation in English-speaking populations. Psychometric testing is underway to determine their measurement properties for evaluating clinical interventions and informing quality of care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201603-198oc","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T17:33:50Z","timestamp":1469640830000},"page":"1726-1735","source":"Crossref","is-referenced-by-count":12,"title":["Primary Ciliary Dyskinesia: First Health-related Quality-of-Life Measures for Pediatric Patients"],"prefix":"10.1093","volume":"13","author":[{"given":"Sharon D.","family":"Dell","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine and"},{"name":"Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Pediatrics and"},{"name":"Institute of Health Policy, Management and Education, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret W.","family":"Leigh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Lucas","sequence":"additional","affiliation":[{"name":"Primary Ciliary Dyskinesia Centre, University Hospital Southampton, National Health Service Foundation Trust, Southampton, United Kingdom"},{"name":"Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Ferkol","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Knowles","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianne","family":"Alpern","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Miami, Coral Gables, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Behan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina"},{"name":"Primary Ciliary Dyskinesia Centre, University Hospital Southampton, National Health Service Foundation Trust, Southampton, United Kingdom"},{"name":"Department of Applied Psychology, University College Cork, Cork, Ireland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana M.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Miami, Coral Gables, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hogg","sequence":"additional","affiliation":[{"name":"Primary Ciliary Dyskinesia Centre, Department of Paediatrics, Royal Brompton and Harefield Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"DunnGalvin","sequence":"additional","affiliation":[{"name":"Department of Applied Psychology, University College Cork, Cork, Ireland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Quittner","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Miami, Coral Gables, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"2026020402524355900_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1164\/rccm.201301-0059CI","article-title":"Primary ciliary dyskinesia: recent advances in diagnostics, genetics, and characterization of clinical disease","volume":"188","author":"Knowles","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524355900_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ppul.23304","article-title":"Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review","volume":"51","author":"Shapiro","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"2026020402524355900_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prrv.2008.05.003","article-title":"Systematic review of health-related quality of life measures for children with respiratory conditions","volume":"9","author":"Quittner","year":"2008","journal-title":"Paediatr Respir Rev"},{"key":"2026020402524355900_bib4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ppul.21569","article-title":"Progression of lung disease in primary ciliary dyskinesia: is spirometry less accurate than CT?","volume":"47","author":"Maglione","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"2026020402524355900_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/thoraxjnl-2011-200726","article-title":"Ventilation inhomogeneity in children with primary ciliary dyskinesia","volume":"67","author":"Green","year":"2012","journal-title":"Thorax"},{"key":"2026020402524355900_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1164\/rccm.201304-0800OC","article-title":"Lung clearance index and high-resolution computed tomography scores in primary ciliary dyskinesia","volume":"188","author":"Irving","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524355900_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thoraxjnl-2014-206578","article-title":"Lung structure\u2013function correlation in patients with primary ciliary dyskinesia","volume":"70","author":"Boon","year":"2015","journal-title":"Thorax"},{"key":"2026020402524355900_bib8","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims","author":"U.S. Department of Health and Human Services","year":"2009"},{"key":"2026020402524355900_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00019053-200119020-00005","article-title":"Health-related quality of life (HR-QOL) and regulatory issues: an assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval","volume":"19","author":"Apolone","year":"2001","journal-title":"Pharmacoeconomics"},{"key":"2026020402524355900_bib10","article-title":"Committee for Medicinal Products for Human Use (CMHP). Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products","author":"European Medicines Agency","year":"2005"},{"key":"2026020402524355900_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cct.2004.09.003","article-title":"Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels","volume":"25","author":"Willke","year":"2004","journal-title":"Control Clin Trials"},{"key":"2026020402524355900_bib12","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","article-title":"Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis","volume":"128","author":"Quittner","year":"2005","journal-title":"Chest"},{"key":"2026020402524355900_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1513\/pats.200703-039BR","article-title":"Patient-reported outcomes in cystic fibrosis","volume":"4","author":"Goss","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"2026020402524355900_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.200712-1804OC","article-title":"Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis","volume":"178","author":"McCoy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524355900_bib15","first-page":"793","article-title":"Measuring health outcomes in pediatric populations: issues in psychometrics and application","volume-title":"Quality of life and pharmacoeconomics in clinical trials","author":"Landgraff","year":"1996"},{"key":"2026020402524355900_bib16","author":"Dell","year":"2014"},{"key":"2026020402524355900_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1164\/rccm.201409-1672OC","article-title":"Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype","volume":"191","author":"Davis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020402524355900_bib18","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1183\/09031936.00176608","article-title":"Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children","volume":"34","author":"Barbato","year":"2009","journal-title":"Eur Respir J"},{"key":"2026020402524355900_bib19","doi-asserted-by":"crossref","first-page":"190\u2013197","DOI":"10.1177\/1468794112446106","article-title":"\u201cUnsatisfactory saturation\u201d: a critical exploration of the notion of saturated sample sizes in qualitative research","volume":"13","author":"O\u2019Reilly","year":"2013","journal-title":"Qual Res"},{"key":"2026020402524355900_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"2026020402524355900_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/poq\/nfm006","article-title":"Research synthesis: the practice of cognitive interviewing","volume":"71","author":"Beatty","year":"2007","journal-title":"Public Opin Q"},{"key":"2026020402524355900_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1183\/09031936.00216214","article-title":"A quality-of-life measure for adults with primary ciliary dyskinesia: QOL-PCD","volume":"46","author":"Lucas","year":"2015","journal-title":"Eur Respir J"},{"key":"2026020402524355900_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s11136-011-0036-z","article-title":"Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample","volume":"21","author":"Quittner","year":"2012","journal-title":"Qual Life Res"},{"key":"2026020402524355900_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","article-title":"Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores","volume":"70","author":"Quittner","year":"2015","journal-title":"Thorax"},{"key":"2026020402524355900_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1378\/chest.13-1891","article-title":"A preliminary Quality of Life Questionnaire-Bronchiectasis: a patient-reported outcome measure for bronchiectasis","volume":"146","author":"Quittner","year":"2014","journal-title":"Chest"},{"key":"2026020402524355900_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcf.2014.11.002","article-title":"Initial evaluation of the Parent Cystic Fibrosis Questionnaire\u2014Revised (CFQ-R) in infants and young children","volume":"14","author":"Alpern","year":"2015","journal-title":"J Cyst Fibros"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/10\/1726\/66663657\/annalsats_13_10_1726.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/13\/10\/1726\/66663657\/annalsats_13_10_1726.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:52:53Z","timestamp":1770191573000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/13\/10\/1726\/8448740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,1]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201603-198oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,10]]},"published":{"date-parts":[[2016,10,1]]}}}